FDA PMA FDA Class 3 Approved 🇺🇸 United States

Kit, Dna Detection, Human Papillomavirus

PMA: P160037 · Supplement: S022 · Decision Aug 25, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
Kit, Dna Detection, Human Papillomavirus
Trade Name
BD ONCLARITY HPV ASSAY
PMA Number
P160037
Supplement Number
S022
Device Class
FDA Class 3
Product Code
MAQ
Generic Name
KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
Medical Specialty
Unknown
Advisory Committee
Microbiology
Decision
Approved
Decision Code
APPR
Decision Date
August 25, 2025
Date Received
February 26, 2025
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Approval for a manufacturing site located at Becton, Dickinson and Company, at 7 Loveton Circle, Sparks, MD, 21152, USA, for the manufacturing of the BD COR PX instrument.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MAQ Kit, Dna Detection, Human Papillomavirus